Belvedere Trading LLC Cue Biopharma, Inc. Put Options Transaction History

Belvedere Trading LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Jul 23, 2021	SELL	$10.9 - $14.53 $247,430 - $329,831	-22,700 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$11.2 - $16.09 $5,600 - $8,045	-500 Reduced 2.16%	22,700 $277,000
Q4 2020 Feb 10, 2021	BUY	$11.12 - $16.4 $257,983 - $380,479	23,200 New	23,200 $290,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $36.1M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.